Purpose: The authors evaluated the utility of Tc-99m-labeled human immunglo
bulin G (HIG) in determining the severity of orbital inflammation and the r
elation of orbital Tc-99m HIG uptake and clinical parameters in patients wi
th Graves' ophthalmopathy.
Materials and Methods: Images were obtained in 23 patients (13 women, 10 me
n; mean age, 51+/-10 years) with Graves' ophthalmopathy. Planar orbital ima
ges were obtained and SPECT was performed using a triple-detector gamma cam
era 4 hours after 370 MBq (10 mCi) Tc-99m HIG injection. Tc-99m HIG uptake
was classified using transaxial and coronal slices as 1, mild; 2, moderate;
and 3, severe. The clinical severity of orbital disease was categorized, a
ccording to the criteria described by Feldon and Unsold, as class I, mild i
nvolvement; class II, moderate; and class III, severe. Disease was consider
ed to be clinically inactive if symptoms and signs were stable or improved
in the last two examinations performed at least 6 months apart.
Results: Sixteen patients were clinically inactive, and seven patients were
active. The mean Tc-99m HIG classes were 1.5+/-0.5 and 2.6+/-0.5, respecti
vely (P = 0.02), There was not a good correlation between the clinical clas
sification and Tc-99m HIG classification, whereas the presence of active di
sease showed a good correlation with Tc-99m HIG classification (1 = 0.703;
P = 0.0002),
Conclusions: Tc-99m HIG imaging showed possible ongoing subclinical inflamm
ation in the orbits of the patients with Graves' ophthalmopathy regardless
of the clinical classification. Tc-99m HIG SPECT seems a promising procedur
e for evaluating the presence of active orbital inflammation.